Claris Ventures SGR

All figures cover the European funds tracked here since 1 January 2025, whether closed or still raising, and are compiled from public sources.

Tracked funds

1

Latest public closing

23 Apr 2025

Reported volume sums the public fund amounts tracked here, not the manager's firm-wide assets under management, so it may differ from totals on the manager's website.

Italian venture capital management company investing in early-stage biopharma and therapeutics companies.

Focus: Early-stage therapeutics and biopharma companies addressing significant unmet medical needs, including company creation around promising science